Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyBiologicalProcessneuron apoptotic process

CHL1 COL6A3 NRBP2 OXR1 ITSN1 HSPH1 NR3C1 ADNP GRM7 CNTFR

1.65e-064137210GO:0051402
GeneOntologyBiologicalProcessnegative regulation of neuron apoptotic process

CHL1 NRBP2 OXR1 ITSN1 HSPH1 ADNP GRM7 CNTFR

1.66e-06236728GO:0043524
GeneOntologyBiologicalProcessregulation of neuron apoptotic process

CHL1 NRBP2 OXR1 ITSN1 HSPH1 NR3C1 ADNP GRM7 CNTFR

3.92e-06355729GO:0043523
GeneOntologyCellularComponentglutamatergic synapse

EEF1D ITSN1 CLTC SCN10A CC2D1A NBEA NR3C1 GRM7 SLC1A7 UNC13A OPHN1

1.18e-048177311GO:0098978
GeneOntologyCellularComponentaxon

MAP6 ITSN1 SCN10A TMOD2 ADNP GRM7 DSCAML1 SLC1A7 UNC13A OPHN1 PTK7

2.51e-048917311GO:0030424
GeneOntologyCellularComponentterminal bouton

GRM7 SLC1A7 UNC13A OPHN1

3.57e-0496734GO:0043195
GeneOntologyCellularComponentpresynaptic membrane

ITSN1 CLTC SCN10A GRM7 SLC1A7 UNC13A

4.15e-04277736GO:0042734
GeneOntologyCellularComponentclathrin complex

CLTC SCN10A

4.26e-049732GO:0071439
GeneOntologyCellularComponentsupramolecular fiber

TLK2 COL6A3 CHMP6 FBXL22 MAP6 HSPH1 BAG3 CLTC TMOD2 SAXO2 MAP10 MYBPC1

7.39e-0411797312GO:0099512
GeneOntologyCellularComponentsupramolecular polymer

TLK2 COL6A3 CHMP6 FBXL22 MAP6 HSPH1 BAG3 CLTC TMOD2 SAXO2 MAP10 MYBPC1

7.84e-0411877312GO:0099081
GeneOntologyCellularComponentaxon terminus

ITSN1 GRM7 SLC1A7 UNC13A OPHN1

8.42e-04210735GO:0043679
GeneOntologyCellularComponentneuron projection terminus

ITSN1 GRM7 SLC1A7 UNC13A OPHN1

1.34e-03233735GO:0044306
GeneOntologyCellularComponentpresynaptic endocytic zone

ITSN1 CLTC

1.77e-0318732GO:0098833
HumanPhenoUpslanted palpebral fissure

TLK2 MYCN ASXL1 SARS1 CHD5 CLTC ADNP CHAMP1 ZNF292

7.06e-06333239HP:0000582
HumanPhenoDisinhibition

TLK2 SARS1 CHD5 CLTC PDZD8 CC2D1A NBEA ADNP CHAMP1 GRM7 OPHN1 ZNF292

5.72e-058072312HP:0000734
HumanPhenoInappropriate behavior

TLK2 SARS1 CHD5 CLTC PDZD8 CC2D1A NBEA ADNP CHAMP1 GRM7 OPHN1 ZNF292

5.72e-058072312HP:0000719
HumanPhenoAbnormal response to social norms

TLK2 SARS1 CHD5 CLTC PDZD8 CC2D1A NBEA ADNP CHAMP1 GRM7 OPHN1 ZNF292

5.72e-058072312HP:5200123
HumanPhenoSocial disinhibition

TLK2 SARS1 CHD5 CLTC PDZD8 CC2D1A NBEA ADNP CHAMP1 GRM7 OPHN1 ZNF292

5.72e-058072312HP:5200029
HumanPhenoRecurrent maladaptive behavior

TLK2 ASXL1 SARS1 CHD5 CLTC PDZD8 CC2D1A NBEA NR3C1 ADNP CHAMP1 GRM7 UNC13A OPHN1 ZNF292

6.33e-0512932315HP:5200241
HumanPhenoHyperactivity

TLK2 CHD5 CLTC PDZD8 CC2D1A NBEA ADNP GRM7 OPHN1 ZNF292

6.97e-055582310HP:0000752
HumanPhenoImpairment in personality functioning

TLK2 SARS1 CHD5 CLTC PDZD8 CC2D1A NBEA NR3C1 ADNP CHAMP1 GRM7 UNC13A OPHN1 ZNF292

7.69e-0511412314HP:0031466
HumanPhenoAbnormally increased volition

TLK2 SARS1 CHD5 CLTC PDZD8 CC2D1A NBEA ADNP CHAMP1 GRM7 OPHN1 ZNF292

1.21e-048692312HP:5200263
HumanPhenoReduced impulse control

TLK2 ASXL1 SARS1 CHD5 CLTC PDZD8 CC2D1A NBEA ADNP CHAMP1 GRM7 OPHN1 ZNF292

1.34e-0410322313HP:5200045
HumanPhenoAbnormal social development

TLK2 SARS1 CHD5 CLTC PDZD8 CC2D1A NBEA ADNP CHAMP1 GRM7 OPHN1 ZNF292

1.88e-049082312HP:0025732
HumanPhenoShort attention span

TLK2 CHD5 CLTC PDZD8 CC2D1A NBEA ADNP OPHN1 ZNF292

2.36e-04517239HP:0000736
HumanPhenoAbnormal motivation

TLK2 SARS1 CHD5 CLTC PDZD8 CC2D1A NBEA NR3C1 ADNP CHAMP1 GRM7 UNC13A OPHN1 ZNF292

2.49e-0412632314HP:5200275
HumanPhenoAbnormal volitional state

TLK2 SARS1 CHD5 CLTC PDZD8 CC2D1A NBEA NR3C1 ADNP CHAMP1 GRM7 UNC13A OPHN1 ZNF292

2.49e-0412632314HP:0025780
HumanPhenoReduced attention regulation

TLK2 CHD5 CLTC PDZD8 CC2D1A NBEA ADNP OPHN1 ZNF292

2.70e-04526239HP:5200044
HumanPhenoAttention deficit hyperactivity disorder

TLK2 CHD5 CLTC PDZD8 NBEA ADNP OPHN1 ZNF292

2.88e-04413238HP:0007018
HumanPhenoTall chin

TLK2 OPHN1

4.04e-047232HP:0400000
HumanPhenoThin upper lip vermilion

TLK2 SARS1 CLTC ADNP CHAMP1 OPHN1 ZNF292

5.25e-04339237HP:0000219
HumanPhenoThin lips

TLK2 SARS1 CLTC ADNP CHAMP1 OPHN1 ZNF292

5.25e-04339237HP:0000213
HumanPhenoLanguage impairment

TLK2 ASXL1 NUP107 OXR1 CHD5 CLTC CC2D1A NBEA ADNP CHAMP1 UNC13A OPHN1 ZNF292

5.45e-0411782313HP:0002463
DomainZnf_PHD

ASXL1 MTF2 BAZ2B CHD5 PHF14

3.04e-0591745IPR001965
DomainZF_PHD_2

ASXL1 MTF2 BAZ2B CHD5 PHF14

3.74e-0595745PS50016
DomainZF_PHD_1

ASXL1 MTF2 BAZ2B CHD5 PHF14

3.93e-0596745PS01359
DomainBAT2_N

PRRC2C PRRC2A

4.63e-053742PF07001
DomainBAT2_N

PRRC2C PRRC2A

4.63e-053742IPR009738
DomainPRRC2

PRRC2C PRRC2A

4.63e-053742IPR033184
DomainFN3

CHL1 COL6A3 IGSF22 DSCAML1 CNTFR MYBPC1

9.23e-05185746SM00060
DomainFN3

CHL1 COL6A3 IGSF22 DSCAML1 CNTFR MYBPC1

1.38e-04199746PS50853
DomainFN3_dom

CHL1 COL6A3 IGSF22 DSCAML1 CNTFR MYBPC1

1.80e-04209746IPR003961
DomainPHD

MTF2 BAZ2B CHD5 PHF14

2.23e-0475744PF00628
DomainZnf_PHD-finger

MTF2 BAZ2B CHD5 PHF14

2.72e-0479744IPR019787
DomainIGc2

CHL1 IGSF22 DSCAML1 CNTFR PTK7 MYBPC1

3.38e-04235746SM00408
DomainIg_sub2

CHL1 IGSF22 DSCAML1 CNTFR PTK7 MYBPC1

3.38e-04235746IPR003598
DomainPHD

MTF2 BAZ2B CHD5 PHF14

4.30e-0489744SM00249
Domainfn3

CHL1 IGSF22 DSCAML1 CNTFR MYBPC1

4.59e-04162745PF00041
DomainIg_I-set

CHL1 IGSF22 DSCAML1 PTK7 MYBPC1

9.44e-04190745IPR013098
DomainI-set

CHL1 IGSF22 DSCAML1 PTK7 MYBPC1

9.44e-04190745PF07679
DomainIG

CHL1 IGSF22 MPIG6B DSCAML1 CNTFR PTK7 MYBPC1

1.38e-03421747SM00409
DomainIg_sub

CHL1 IGSF22 MPIG6B DSCAML1 CNTFR PTK7 MYBPC1

1.38e-03421747IPR003599
DomainC2

ITSN1 CC2D1A C2CD2 UNC13A

1.82e-03131744PF00168
DomainC2

ITSN1 CC2D1A C2CD2 UNC13A

2.14e-03137744SM00239
DomainZinc_finger_PHD-type_CS

MTF2 CHD5 PHF14

2.19e-0365743IPR019786
DomainC2

ITSN1 CC2D1A C2CD2 UNC13A

2.44e-03142744PS50004
DomainZnf_FYVE_PHD

MTF2 BAZ2B CHD5 PHF14

2.77e-03147744IPR011011
Domain-

ITSN1 CC2D1A C2CD2 UNC13A

2.83e-031487442.60.40.150
DomainC2_dom

ITSN1 CC2D1A C2CD2 UNC13A

4.09e-03164744IPR000008
DomainTUDOR

ARID4B MTF2

5.10e-0327742SM00333
DomainTudor

ARID4B MTF2

6.27e-0330742IPR002999
DomainChromodomain-like

ARID4B CHD5

7.11e-0332742IPR016197
DomainChromo/shadow_dom

ARID4B CHD5

7.55e-0333742IPR000953
DomainCHROMO

ARID4B CHD5

7.55e-0333742SM00298
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

TLK2 NOLC1 MYCN SRRM1 ARID4B SF3A1 ITSN1 BAG3 RALGAPB CLTC SORBS3 PHF14 CHAMP1 PRRC2A

1.04e-09774751415302935
Pubmed

The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.

NOLC1 SRRM1 EEF1D ARID4B BAZ2B PRRC2C SF3A1 CLTC PHF14 ADNP ZNF512 CHAMP1 PRRC2A TASOR2

1.47e-08954751436373674
Pubmed

The in vivo Interaction Landscape of Histones H3.1 and H3.3.

SRRM1 ARID4B MTF2 BAZ2B CHD5 MASTL PHF14 ADNP ZNF512 CHAMP1 ZNF292

7.59e-08608751136089195
Pubmed

Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.

NOLC1 SRRM1 TBC1D31 SARS1 NUP107 SF3A1 ITSN1 HSPH1 BAG3 RALGAPB CLTC PDZD8 CC2D1A NR3C1 ZNF512 PTK7

9.05e-081487751633957083
Pubmed

NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.

NOLC1 SRRM1 CHD5 PHF14 ADNP CHAMP1

9.94e-0810375632744500
Pubmed

A probability-based approach for high-throughput protein phosphorylation analysis and site localization.

NOLC1 SRRM1 NUP107 HSPH1 BAG3 SORBS3 MASTL CC2D1A CHAMP1 PRRC2A

1.31e-07503751016964243
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

NOLC1 SRRM1 EEF1D TBC1D31 PPRC1 PRRC2C ITSN1 CHD5 HSPH1 CLTC PHF14 TASOR2 PTK7 MYBPC1 ZNF292

3.75e-071442751535575683
Pubmed

PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.

TLK2 NOLC1 EEF1D MED6 BAZ2B PRRC2C SF3A1 HSPH1 CLTC CC2D1A ADNP PRRC2A ZNF292

6.26e-071103751334189442
Pubmed

N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.

NOLC1 NUP107 PRRC2C SF3A1 HSPH1 BAG3 MASTL CC2D1A NR3C1 ADNP CHAMP1 PRRC2A

7.25e-07934751233916271
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

NOLC1 SRRM1 NUP107 PRRC2C SF3A1 CLTC ADNP ZNF512 PRRC2A TASOR2

1.41e-06653751022586326
Pubmed

Human transcription factor protein interaction networks.

NOLC1 ASXL1 EEF1D ARID4B NUP107 PRRC2C CHD5 HSPH1 TMOD2 CC2D1A ELK4 ADNP ZNF512 PRRC2A

1.96e-061429751435140242
Pubmed

KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.

NHSL1 EEF1D SARS1 OXR1 MAP6 PRRC2C ITSN1 HSPH1 CLTC TMOD2 NBEA PRRC2A UNC13A OPHN1

2.00e-061431751437142655
Pubmed

ELK4 targets CHMP6 to inhibit ferroptosis and enhance malignant properties of skin cutaneous melanoma cells.

CHMP6 ELK4

4.59e-06275239305302
Pubmed

MYC multimers shield stalled replication forks from RNA polymerase.

TLK2 NOLC1 EEF1D SF3A1 HSPH1 BAG3 CLTC PDZD8 PHF14 ADNP CHAMP1

8.65e-06989751136424410
Pubmed

Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.

SRRM1 OXR1 ITSN1 HSPH1 NBEA GRM7 PRRC2A

1.03e-0534775717114649
Pubmed

Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.

NHSL1 TBC1D31 NUP107 BAG3 RALGAPB CLTC SORBS3 PDZD8 NBEA ZNF512 PRRC2A

1.50e-051049751127880917
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

OXR1 PPRC1 HECTD2 RALBP1 ITSN1 HSPH1 CLTC PDZD8 NBEA PRRC2A DSCAML1 ZNF292

1.87e-051285751235914814
Pubmed

Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.

SRRM1 RALBP1 SF3A1 ITSN1 SELENOH BAG3 TMOD2 NBEA PRRC2A OPHN1

2.70e-05916751032203420
Pubmed

Intersectin-s interaction with DENND2B facilitates recycling of epidermal growth factor receptor.

ITSN1 DENND2B

2.75e-05475229030480
Pubmed

Transcription factor protein interactomes reveal genetic determinants in heart disease.

EEF1D CHMP6 MTF2 BAZ2B SF3A1 ADNP TASOR2

3.04e-0541175735182466
Pubmed

The ubiquitin ligase Uhrf2 is a master regulator of cholesterol biosynthesis and is essential for liver regeneration.

NOLC1 ADNP CHAMP1 TASOR2

3.70e-058675437253089
Pubmed

Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.

NOLC1 SRRM1 EEF1D SARS1 PRRC2C SF3A1 HSPH1 BAG3 CLTC CC2D1A CHAMP1 PRRC2A

4.78e-051415751228515276
Pubmed

CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.

NOLC1 SRRM1 PRRC2C SF3A1 CHD5 PHF14 ADNP ZNF512

4.85e-0560575828977666
Pubmed

Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.

NOLC1 SRRM1 EEF1D MED6 SARS1 NUP107 SF3A1 HSPH1 BAG3 CLTC PRRC2A

7.20e-051247751127684187
Pubmed

Cross-linking mass spectrometry reveals the structural topology of peripheral NuRD subunits relative to the core complex.

MAP6 CHD5 ADNP

7.70e-053875333283408
Pubmed

ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex.

NOLC1 MTF2 SF3A1 CHD5 PHF14 ZNF512

8.10e-0533075633301849
Pubmed

Transferrin Receptor Protein 1 Cooperates with mGluR2 To Mediate the Internalization of Rabies Virus and SARS-CoV-2.

SRRM1 EEF1D HSPH1 CLTC ZNF512 PRRC2A

8.51e-0533375636779763
Pubmed

Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.

MYCN ASXL1 EEF1D ARID4B NUP107 PRRC2C SF3A1 NR3C1 ADNP

9.43e-0585775925609649
Pubmed

Additional sex comb-like 1 (ASXL1), in cooperation with SRC-1, acts as a ligand-dependent coactivator for retinoic acid receptor.

ASXL1 NR3C1

9.57e-05775216606617
Pubmed

H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.

NOLC1 SRRM1 MED6 ARID4B NUP107 MTF2 BAZ2B SF3A1 PHF14 ADNP CHAMP1

1.00e-041294751130804502
Pubmed

A conserved acetylation switch enables pharmacological control of tubby-like protein stability.

TLK2 NHSL1 SORBS3 ZBED1 ZNF292

1.24e-0422375533187986
Pubmed

Disruption of MeCP2-TCF20 complex underlies distinct neurodevelopmental disorders.

PHF14 CHAMP1

1.27e-04875235074918
Pubmed

Microtubule-associated protein 6 mediates neuronal connectivity through Semaphorin 3E-dependent signalling for axonal growth.

MAP6 ITSN1

1.27e-04875226037503
Pubmed

ATG5 is required for B cell polarization and presentation of particulate antigens.

EEF1D MED6 PRRC2C RALBP1 SELENOH CLTC NR3C1 PRRC2A

1.35e-0470175830196744
Pubmed

An improved smaller biotin ligase for BioID proximity labeling.

NUP107 PRRC2C GRM7 ZNF292

1.49e-0412375426912792
Pubmed

Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.

NOLC1 SRRM1 SELENOH CLTC CC2D1A ADNP ZNF512

1.54e-0453375730554943
Pubmed

A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.

TLK2 SARS1 PRRC2C HSPH1 CC2D1A ZNF512 PRRC2A ZNF292

1.68e-0472475836232890
Pubmed

The Activation-Induced Assembly of an RNA/Protein Interactome Centered on the Splicing Factor U2AF2 Regulates Gene Expression in Human CD4 T Cells.

SRRM1 EEF1D SF3A1 HSPH1 CLTC

1.71e-0423975526641092
Pubmed

Tumor suppressor BAP1 nuclear import is governed by transportin-1.

SRRM1 EEF1D SARS1 PRRC2C SF3A1 HSPH1 BAG3 CLTC NR3C1 PRRC2A

1.76e-041149751035446349
Pubmed

SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.

PRRC2C BAG3 CLTC CC2D1A ADNP CHAMP1 PRRC2A

1.85e-0454975738280479
Pubmed

E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.

SARS1 BAZ2B ITSN1 HSPH1 CLTC PHF14 NBEA DSCAML1

1.87e-0473675829676528
Pubmed

Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.

EEF1D PRRC2C SF3A1 HSPH1 CLTC PRRC2A TASOR2

1.89e-0455175734728620
Pubmed

Stonin1 mediates endocytosis of the proteoglycan NG2 and regulates focal adhesion dynamics and cell motility.

ITSN1 CLTC

2.04e-041075226437238
Pubmed

WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.

SRRM1 HSPH1 PHF14 ZNF512 CHAMP1 PRRC2A

2.12e-0439475627248496
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

TLK2 MAP6 PRRC2C ITSN1 CLTC NBEA ADNP PRRC2A UNC13A

2.26e-0496375928671696
Pubmed

Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling.

SRRM1 EEF1D PRRC2C SF3A1 BAG3 PRRC2A

2.27e-0439975635987950
Pubmed

Comparative proximity biotinylation implicates the small GTPase RAB18 in sterol mobilization and biosynthesis.

EEF1D PRRC2C HSPH1 BAG3 PDZD8 CC2D1A C2CD2

2.27e-0456875737774976
Pubmed

Binding of human nucleotide exchange factors to heat shock protein 70 (Hsp70) generates functionally distinct complexes in vitro.

HSPH1 BAG3

2.49e-041175224318877
Pubmed

The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.

ARID4B NUP107 SF3A1 HSPH1 CLTC ADNP CHAMP1

2.66e-0458375729844126
Pubmed

A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease.

NOLC1 PPRC1 HECTD2 BAG3 MASTL PDZD8

2.80e-0441575616385451
Pubmed

Functional kinomics establishes a critical node of volume-sensitive cation-Cl- cotransporter regulation in the mammalian brain.

TLK2 MASTL

2.99e-041275227782176
Pubmed

Endofin is required for HD-PTP and ESCRT-0 interdependent endosomal sorting of ubiquitinated transmembrane cargoes.

ITSN1 CLTC CC2D1A

3.02e-046075334761192
Pubmed

RNF43 G659fs is an oncogenic colorectal cancer mutation and sensitizes tumor cells to PI3K/mTOR inhibition.

NUP107 CHD5 HSPH1 BAG3

3.03e-0414875435676246
Pubmed

Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing.

EEF1D SF3A1 CHD5 PHF14 TASOR2

3.06e-0427175532433965
Pubmed

Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.

ITSN1 CHD5 CLTC SCN10A ADNP TASOR2

3.38e-0443075635044719
Pubmed

FCHo proteins are nucleators of clathrin-mediated endocytosis.

ITSN1 CLTC

3.52e-041375220448150
Pubmed

BAG5 Promotes Alpha-Synuclein Oligomer Formation and Functionally Interacts With the Autophagy Adaptor Protein p62.

PRRC2C HSPH1 BAG3 CLTC

3.70e-0415675432850835
Pubmed

MBD5 and MBD6 stabilize the BAP1 complex and promote BAP1-dependent cancer.

ASXL1 EEF1D SF3A1 HSPH1 CLTC

3.98e-0428775536180891
Pubmed

MED25 is distinct from TRAP220/MED1 in cooperating with CBP for retinoid receptor activation.

MED6 NR3C1

4.11e-041475217641689
Pubmed

Redundant and nonredundant organismal functions of EPS15 and EPS15L1.

ITSN1 CLTC

4.11e-041475230692166
Pubmed

Genome-wide siRNA screen reveals amino acid starvation-induced autophagy requires SCOC and WAC.

TLK2 NRBP2

4.11e-041475222354037
Pubmed

Enoyl-CoA hydratase-1 regulates mTOR signaling and apoptosis by sensing nutrients.

BAZ2B PRRC2A

4.11e-041475228878358
Pubmed

Role of the AP2 beta-appendage hub in recruiting partners for clathrin-coated vesicle assembly.

ITSN1 CLTC

4.11e-041475216903783
Pubmed

Cloning of ligand targets: systematic isolation of SH3 domain-containing proteins.

ITSN1 SORBS3

4.73e-04157529630982
Pubmed

Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non-synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopment.

NBEA NR3C1 GRM7 SLC1A7 CNTFR

4.87e-0430075519086053
Pubmed

MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.

NOLC1 SRRM1 MAP6 SF3A1 CLTC ADNP CHAMP1 UNC13A ZNF292

5.27e-04108275938697112
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

NOLC1 NHSL1 SRRM1 PRRC2C BAG3 RALGAPB CC2D1A DENND2B

5.34e-0486175836931259
Pubmed

Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.

TLK2 NOLC1 TBC1D31 MAP6 PPRC1 ITSN1 HSPH1 CLTC MASTL

5.34e-04108475911544199
Pubmed

Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.

NOLC1 NUP107 MTF2 PRRC2C PHF14 TASOR2

5.35e-0446975627634302
Pubmed

Characterization of human colon cancer antigens recognized by autologous antibodies.

EEF1D HSPH1

5.40e-04167529610721
Pubmed

Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.

TLK2 SRRM1 ARID4B MTF2 SF3A1 HSPH1 RALGAPB CLTC PHF14 ZNF292

5.50e-041327751032694731
Pubmed

Activity-dependent neuroprotective protein recruits HP1 and CHD4 to control lineage-specifying genes.

ADNP CHAMP1 ZNF292

5.59e-047475329795351
Pubmed

Systematic interactome mapping of acute lymphoblastic leukemia cancer gene products reveals EXT-1 tumor suppressor as a Notch1 and FBWX7 common interactor.

ZGRF1 ZNF839 ZBED1 TASOR2

5.82e-0417675427229929
Pubmed

Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells.

TLK2 HSPH1 ADNP CHAMP1

6.07e-0417875427637333
Pubmed

LINC00240 in the 6p22.1 risk locus promotes gastric cancer progression through USP10-mediated DDX21 stabilization.

PRRC2C PRRC2A

6.11e-041775237072811
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

NHSL1 CHMP6 PPRC1 CHD5 SORBS3 PDZD8 CC2D1A ZNF839 C2CD2

6.12e-04110575935748872
Pubmed

TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex.

COL6A3 SF3A1 HSPH1 CLTC

6.20e-0417975436261009
Pubmed

Genome-wide meta-analysis identifies new susceptibility loci for migraine.

NBEA NR3C1 IRAG1

6.52e-047875323793025
Pubmed

PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation.

SRRM1 PRRC2C HSPH1 BAG3 CLTC ZNF512 PRRC2A

6.54e-0467875730209976
Pubmed

Misregulation of an Activity-Dependent Splicing Network as a Common Mechanism Underlying Autism Spectrum Disorders.

ITSN1 NBEA

6.87e-041875227984743
Pubmed

Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.

NOLC1 SRRM1 EEF1D SF3A1 HSPH1 BAG3 CLTC NR3C1 ADNP CHAMP1

6.92e-041367751032687490
Pubmed

CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.

NOLC1 EEF1D NUP107 SF3A1 HSPH1 CLTC

7.01e-0449475626831064
Pubmed

HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.

SRRM1 EEF1D PRRC2C RALBP1 SF3A1 HSPH1 SELENOH CLTC CC2D1A PRRC2A

7.08e-041371751036244648
Pubmed

Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.

ASXL1 RALGAPB NBEA ADNP CNTFR

7.38e-0432975517474147
Pubmed

Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.

NOLC1 NHSL1 EEF1D MAP6 PRRC2C CLTC NBEA UNC13A PTK7

7.59e-04113975936417873
Pubmed

Interactions of the Antiviral Factor Interferon Gamma-Inducible Protein 16 (IFI16) Mediate Immune Signaling and Herpes Simplex Virus-1 Immunosuppression.

SRRM1 NUP107 PHF14 ZNF512 PRRC2A

7.69e-0433275525693804
Pubmed

The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.

ASXL1 PRRC2C ITSN1 CLTC PRRC2A

7.69e-0433275537433992
Pubmed

Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.

SARS1 NUP107 SF3A1 CLTC CHAMP1

7.69e-0433275532786267
Pubmed

A comprehensive resource of interacting protein regions for refining human transcription factor networks.

EEF1D ARID4B NR3C1 PRRC2A

7.90e-0419175420195357
Pubmed

Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.

NOLC1 SRRM1 SF3A1 CLTC TMOD2 ADNP

7.94e-0450675630890647
Pubmed

TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions.

SRRM1 ASXL1 EEF1D ARID4B HSPH1 CLTC PHF14 PRRC2A

8.33e-0492275827609421
Pubmed

Systematic analysis of human protein complexes identifies chromosome segregation proteins.

TLK2 NOLC1 ASXL1 NUP107 SF3A1 CLTC MASTL CHAMP1 TASOR2

8.38e-04115575920360068
Pubmed

Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.

NOLC1 NUP107 SF3A1 ADNP CHAMP1

8.66e-0434175532971831
Pubmed

Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.

EEF1D PRRC2C SF3A1 HSPH1 CLTC TMOD2 PRRC2A

8.85e-0471475728302793
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: I. The complete nucleotide sequences of 100 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

NBEA DSCAML1 ZNF292

8.96e-048775312465718
Pubmed

Defining the membrane proteome of NK cells.

MED6 CHMP6 NUP107 PRRC2C CHD5 CLTC PDZD8 CC2D1A PRRC2A

9.06e-04116875919946888
Pubmed

Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.

NOLC1 EEF1D SARS1 NUP107 SF3A1 HSPH1 CLTC ADNP ZNF512 MYBPC1

9.50e-041425751030948266
Pubmed

LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.

NUP107 PRRC2C CLTC PRRC2A

9.73e-0420275433005030
Pubmed

TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.

NOLC1 SRRM1 EEF1D SF3A1 CHD5 HSPH1 CLTC DENND2B

1.00e-0394975836574265
Pubmed

Mammalian splicing factor SF1 interacts with SURP domains of U2 snRNP-associated proteins.

SF3A1 CLTC

1.03e-032275226420826
InteractionCEBPA interactions

TLK2 NOLC1 ASXL1 EEF1D MED6 NUP107 BAZ2B PRRC2C SF3A1 HSPH1 CLTC CC2D1A NR3C1 ADNP PRRC2A ZNF292

7.58e-0612457316int:CEBPA
InteractionPRC1 interactions

NOLC1 MYCN SRRM1 NUP107 BAZ2B SF3A1 CHD5 HSPH1 CLTC TMOD2 PHF14 CHAMP1 UNC13A MYBPC1

8.78e-069737314int:PRC1
InteractionCSNK2A2 interactions

NOLC1 MYCN SRRM1 MED6 ARID4B PRRC2C SF3A1 HSPH1 CLTC PHF14 NR3C1 ADNP

9.56e-067187312int:CSNK2A2
InteractionSMC5 interactions

NOLC1 SRRM1 EEF1D ARID4B BAZ2B PRRC2C SF3A1 CLTC PHF14 ADNP ZNF512 CHAMP1 PRRC2A TASOR2

1.20e-0510007314int:SMC5
InteractionCHD3 interactions

NOLC1 SRRM1 ARID4B MTF2 PRRC2C SF3A1 CHD5 HSPH1 PHF14 ADNP ZNF512 ZBED1

1.62e-057577312int:CHD3
InteractionHSPA2 interactions

MYCN PRRC2C SF3A1 CHD5 HSPH1 BAG3 CLTC CC2D1A ADNP

2.93e-05440739int:HSPA2
InteractionCLTA interactions

MYCN ITSN1 HSPH1 BAG3 CLTC CC2D1A NBEA NR3C1

3.92e-05351738int:CLTA
InteractionSMARCC2 interactions

MYCN SRRM1 ARID4B IFTAP SF3A1 ITSN1 NR3C1 ADNP

4.08e-05353738int:SMARCC2
InteractionADNP2 interactions

CHD5 ADNP CHAMP1 ZNF292

4.37e-0554734int:ADNP2
InteractionGPSM1 interactions

RALBP1 ZBED1 CHAMP1 TASOR2

4.70e-0555734int:GPSM1
InteractionEED interactions

CHL1 NOLC1 MYCN SRRM1 ASXL1 EEF1D TBC1D31 ARID4B NUP107 MTF2 BAZ2B SF3A1 HSPH1 CLTC ADNP TASOR2

4.76e-0514457316int:EED
InteractionNUMA1 interactions

MYCN SRRM1 NUP107 MTF2 PDZD8 PHF14 ADNP ZNF512 CHAMP1

4.81e-05469739int:NUMA1
InteractionSCAI interactions

ITSN1 ADNP CHAMP1 ZNF292

6.63e-0560734int:SCAI
InteractionSIRT7 interactions

NOLC1 SRRM1 NUP107 PRRC2C SF3A1 CLTC ELK4 ADNP ZNF512 PRRC2A TASOR2

7.12e-057447311int:SIRT7
InteractionH3C3 interactions

SRRM1 MTF2 BAZ2B CHD5 PHF14 ADNP ZNF512 CHAMP1 ZNF292

7.28e-05495739int:H3C3
InteractionARHGAP26 interactions

RALBP1 SORBS3 NR3C1 C2CD2 OPHN1

7.48e-05120735int:ARHGAP26
InteractionH3-3A interactions

MYCN ARID4B RALBP1 CHD5 MASTL PHF14 ELK4 ADNP ZNF512 CHAMP1 ZNF292

7.56e-057497311int:H3-3A
InteractionBAG2 interactions

MYCN ASXL1 PRRC2C SF3A1 CHD5 BAG3 CLTC NR3C1 ADNP PTK7

7.87e-056227310int:BAG2
InteractionCCDC6 interactions

SARS1 NUP107 RALBP1 SF3A1 ITSN1 SORBS3 NR3C1

7.89e-05286737int:CCDC6
InteractionNUP43 interactions

SRRM1 ARID4B NUP107 BAZ2B PRRC2C ZNF512 CHAMP1 GRM7 TASOR2 ZNF292

8.19e-056257310int:NUP43
InteractionSYNE1 interactions

MYCN NUP107 SF3A1 ITSN1 OPHN1

8.41e-05123735int:SYNE1
InteractionSNRNP40 interactions

TLK2 MYCN SRRM1 BAZ2B SF3A1 CLTC MASTL PDZD8 ZNF512 TASOR2

9.58e-056377310int:SNRNP40
InteractionPHF19 interactions

MYCN NRBP2 MTF2 CHAMP1

9.63e-0566734int:PHF19
InteractionCBX3 interactions

TLK2 MYCN SRRM1 CHD5 CLTC MASTL ADNP ZNF512 CHAMP1 ZNF292

1.08e-046467310int:CBX3
InteractionH1-4 interactions

NOLC1 MYCN ASXL1 EEF1D PPRC1 RALBP1 HSPH1 PDZD8 ZNF512 TASOR2

1.22e-046567310int:H1-4
InteractionCHMP4A interactions

MYCN CHMP6 PDZD8 CC2D1A

1.35e-0472734int:CHMP4A
InteractionHDAC1 interactions

NOLC1 MYCN ARID4B NUP107 RALBP1 ZGRF1 SF3A1 CHD5 HSPH1 BAG3 PHF14 NR3C1 ADNP

1.55e-0411087313int:HDAC1
InteractionFOXK2 interactions

MYCN ASXL1 ARID4B NUP107 PRRC2C ADNP

1.65e-04225736int:FOXK2
InteractionBCLAF1 interactions

NOLC1 MYCN SRRM1 ASXL1 SF3A1 BAG3 ELK4

1.81e-04327737int:BCLAF1
InteractionEFTUD2 interactions

NOLC1 MYCN SRRM1 ASXL1 EEF1D SARS1 PRRC2C SF3A1 HSPH1 BAG3 CLTC PDZD8 CC2D1A CHAMP1 PRRC2A

1.81e-0414497315int:EFTUD2
InteractionKLF8 interactions

NOLC1 ARID4B PRRC2C HSPH1 ADNP ZNF512 PRRC2A

1.88e-04329737int:KLF8
InteractionNAA40 interactions

NOLC1 NUP107 PRRC2C SF3A1 HSPH1 BAG3 MASTL CC2D1A NR3C1 ADNP CHAMP1 PRRC2A

1.90e-049787312int:NAA40
InteractionRAB4A interactions

OXR1 HSPH1 BAG3 RALGAPB PDZD8 CC2D1A NBEA NR3C1

2.43e-04457738int:RAB4A
InteractionRBMX interactions

MYCN SRRM1 ASXL1 SF3A1 CLTC SORBS3 PDZD8 PRRC2A

2.58e-04461738int:RBMX
InteractionDAXX interactions

NOLC1 MYCN PHF14 NR3C1 ADNP CHAMP1 TASOR2

2.88e-04353737int:DAXX
InteractionMBD2 interactions

ARID4B MTF2 CHD5 HSPH1 NR3C1

2.96e-04161735int:MBD2
InteractionMYBL2 interactions

ARID4B MTF2 CHD5 CLTC NR3C1

3.05e-04162735int:MYBL2
Cytoband10q24.32

NOLC1 PPRC1

7.29e-042476210q24.32
Cytoband11p15

IRAG1 DENND2B

2.34e-034376211p15
CytobandEnsembl 112 genes in cytogenetic band chr3p26

CHL1 GRM7

3.02e-0349762chr3p26
GeneFamilyFibronectin type III domain containing

CHL1 IGSF22 DSCAML1 CNTFR MYBPC1

5.21e-05160465555
GeneFamilyBlood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing

CHL1 IGSF22 DSCAML1 PTK7 MYBPC1

5.37e-05161465593
GeneFamilyPHD finger proteins

MTF2 BAZ2B CHD5 PHF14

7.98e-059046488
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

ITSN1 CC2D1A C2CD2

1.04e-0436463823
GeneFamilyImmunoglobulin like domain containing

CHL1 DSCAML1 CNTFR PTK7

1.45e-03193464594
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_DN

TLK2 ASXL1 TBC1D31 MTF2 BAZ2B PRRC2C ITSN1 PHF14 NR3C1 ADNP DENND2B C2CD2 ZNF292

8.56e-078567513M4500
ToppCell(09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition

SRRM1 ARID4B BAZ2B PRRC2C ITSN1 HSPH1 ADNP ZNF292

1.85e-09199768fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell(08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition

SRRM1 ARID4B PRRC2C RALBP1 ITSN1 ZNF292

1.37e-07138766817e3f639604ea95adae01e8685ffaa2e0aff7a8
ToppCellBrain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type.

ARID4B MTF2 BAZ2B PRRC2C PHF14 CNTFR

7.67e-07185766857c7ca8493e91ef1d0078ddafd6082020f9b169
ToppCellLPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

COL6A3 BAZ2B HECTD2 ITSN1 IRAG1 CNTFR

1.17e-06199766e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b
ToppCell(04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition

SRRM1 ARID4B PRRC2C RALBP1 HSPH1 ZNF292

1.17e-0619976653ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCellLPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type

COL6A3 BAZ2B NBEA IRAG1 CNTFR PTK7

1.21e-06200766a9ff3210127000b3dd9e97136163c98c2b0817d7
ToppCelldroplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SRRM1 ARID4B PRRC2C ELK4 NR3C1

1.35e-0517876501dafd19de04eff459253eaa9a35debf8f3deedf
ToppCelldroplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SRRM1 ARID4B BAZ2B PRRC2C ELK4

1.50e-05182765eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c
ToppCellTCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9

ASXL1 HSPH1 RALGAPB PHF14 ADNP

1.75e-0518876514bc73cf79c79c9f208369fd8d498e5b26e0114d
ToppCellLPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL6A3 FBXL22 HECTD2 IRAG1 CNTFR

1.75e-051887653177b2c1723268d330d3e9f24f9e24492ace6286
ToppCell10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CHL1 TMOD2 GRM7 DSCAML1 OPHN1

1.85e-051907656c7e1086c0a274cd5527c3104106e372811c9905
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

COL6A3 SORBS3 IRAG1 DENND2B UNC13A

1.89e-0519176504c4d454b57e29a8d1dcdeb4678ce71bdc29b77b
ToppCell10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-T_follicular_helper_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

TRABD2A EEF1D SF3A1 HSPH1 MASTL

1.94e-051927653e2a0f332e7f9833ba88f3c809cee78b65090401
ToppCellhuman_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells)

ASXL1 ARID4B PRRC2C HSPH1 ZNF292

1.99e-05193765e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

NOLC1 ASXL1 PPRC1 HSPH1 BAG3

1.99e-05193765dbf0fe496254320c894568c31e5f9ce63707d1b5
ToppCellsaliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)

CHL1 ADH7 PPRC1 BAG3 NBEA

2.20e-05197765d6c9da7a3a6d2bcb13e2fc6605c8a59e7fb121c5
ToppCellH1299-infected-SARSCoV2|infected / Cell line, Condition and Strain

EEF1D PRRC2C PHF14 PRRC2A ZNF292

2.20e-051977650fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

COL6A3 BAG3 PHF14 IRAG1 DENND2B

2.20e-05197765888f3b14133e078570ce4ad73d9a9ee3137f9cac
ToppCellsaliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)

CHL1 ADH7 PPRC1 BAG3 NBEA

2.20e-0519776580b05c8ad9c1edc5dea3236079372475431343fe
ToppCell3'-Adult-Distal_Rectal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TRABD2A PRRC2C RALBP1 HSPH1 BAG3

2.25e-051987657ad7726fc405806b1d7824f58548073ea5e0c70b
ToppCell3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TRABD2A PRRC2C RALBP1 HSPH1 BAG3

2.25e-051987651fbec311f2c987ca90a023a5989128c05aa12d5c
ToppCell3'-Adult-Distal_Rectal-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TRABD2A PRRC2C RALBP1 HSPH1 BAG3

2.25e-05198765ceede961ad9af6a3159db7efaa5087bf38aafc2d
ToppCell3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TRABD2A PRRC2C RALBP1 HSPH1 BAG3

2.25e-051987654f26a60e99f42343e5af7221723e108a1a1b7827
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster

ARID4B BAZ2B PRRC2C PHF14 ZNF292

2.25e-05198765de5214a85fe017eb23d4aa8af624464f062ec57e
ToppCellBrain_organoid-organoid_Velasco_nature-3_mon-Neuronal-CPNs|3_mon / Sample Type, Dataset, Time_group, and Cell type.

CHL1 MYCN NHSL1 CHD5 NBEA

2.25e-0519876560d8d3bbd754ffde41c50013d822667b185a9751
ToppCell(03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition

SRRM1 BAZ2B PRRC2C RALBP1 ZNF292

2.30e-05199765c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCellLPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

CHL1 COL6A3 ITSN1 CNTFR PTK7

2.30e-0519976538ed3bc7daa993d9edcf3e7834597ebb06dd24f8
ToppCell(00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition

SRRM1 PRRC2C RALBP1 HSPH1 ZNF292

2.30e-0519976519674e1eaeb51e4196d847cb62aa437c852951d3
ToppCell(05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition

SRRM1 PRRC2C RALBP1 ITSN1 ZNF292

2.30e-05199765d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

SRRM1 TRABD2A ASXL1 EEF1D PRRC2C

2.30e-051997653003badee037d4d63a8018a74c0aea213d049e43
ToppCellLPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

COL6A3 BAZ2B IRAG1 CNTFR PTK7

2.30e-0519976538cfd367ee8c074c11ba54edeb7a001e375e2687
ToppCellLPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

COL6A3 HECTD2 ITSN1 IRAG1 CNTFR

2.36e-052007658988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e
ToppCellLPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

COL6A3 BAZ2B HECTD2 IRAG1 CNTFR

2.36e-0520076508bf8c00eee6468215edb3611296bfc8784c4d56
ToppCellLPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type

COL6A3 HECTD2 ITSN1 IRAG1 CNTFR

2.36e-0520076502cae2c296a13ad4cbb53bca7a86d64629d67d66
ToppCellCOVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class

SRRM1 ARID4B PRRC2C NR3C1 ZNF292

2.36e-0520076562c25042086f1afd1102e0720e933c2e476468fd
ToppCellLPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

COL6A3 HECTD2 ITSN1 IRAG1 CNTFR

2.36e-0520076587827041663013f5e7273168dc8709d69840e7ce
ToppCell3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

COL6A3 BAZ2B PHF14 CNTFR PTK7

2.36e-05200765ac8a5d71acd4d401995babd233f0d3738e8ad2a5
ToppCellLPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

COL6A3 BAZ2B IRAG1 CNTFR PTK7

2.36e-0520076509537dc25f8b8b4654a7c183827ee1522a41a4e0
ToppCellLPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

COL6A3 FBXL22 HECTD2 ITSN1 IRAG1

2.36e-05200765c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital|World / Primary Cells by Cluster

CHL1 NHSL1 MAP6 PHF14 NBEA

2.36e-052007656bbe8e1f3e91678f1bfb14945365c1578a59a604
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital-19|World / Primary Cells by Cluster

CHL1 NHSL1 MAP6 PHF14 NBEA

2.36e-05200765c831d9e0a7178e3634da45548f91fa9e8dc6557c
ToppCellLPS-IL1RA+antiTNF-Unknown-Endothelial-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

IFTAP MASTL CC2D1A IRAG1

1.40e-0415476416fdafb5c64d2db321554f87129a962d113f1668
ToppCell390C-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

NRBP2 TBC1D31 CC2D1A ZNF839

1.66e-041617642fe77af3b41e6eacb707a64feea18f9991618173
ToppCell10x5'-GI_large-bowel-Lymphocytic_T_CD8-Tem/emra_CD8|GI_large-bowel / Manually curated celltypes from each tissue

NHSL1 NBEA SLC1A7 OPHN1

1.86e-0416676413bef304ea3df8e8d2bc376a3287c78220a1b0c6
ToppCellCOVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type

HEMGN GRM7 UNC13A MYBPC1

2.09e-04171764b2e753e811a7639956994609f73efcdb62d04f82
ToppCelldroplet-Liver-Npc-18m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TBC1D31 ITSN1 CHAMP1 DSCAML1

2.18e-041737649ba55e21d1037ec3150d77895e52f0b051df65da
ToppCellControl-CD4+_T_activated|Control / Disease group and Cell class

IGSF22 NRBP2 FBXL22 HSPH1

2.23e-041747642b683e81b315ad22555314433aed5681feb48da8
ToppCell5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

MYCN MAP6 GRM7 DSCAML1

2.23e-0417476416204ff504b7b382b4d90ca35003ad5336020e07
ToppCell5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CHL1 COL6A3 HECTD2 DENND2B

2.23e-04174764f90ca117b729436cf452e2ddcec26ba525c5c13b
ToppCelldroplet-Liver-LIVER-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FBXL22 SORBS3 ELK4 PTK7

2.33e-041767644d2fb51e71bed0d72f3d7f89d395744860885a5f
ToppCelldroplet-Liver-LIVER-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FBXL22 SORBS3 ELK4 PTK7

2.33e-041767644880fa20b50eb10358e08567e08559ef2954f237
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

COL6A3 DENND2B UNC13A PTK7

2.33e-041767649bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c
ToppCelldroplet-Liver-LIVER-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FBXL22 SORBS3 ELK4 PTK7

2.33e-04176764fcdddd949ca05b3ecde240db9e38296a6eab2d6a
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

COL6A3 DENND2B UNC13A PTK7

2.33e-041767643f8274a7ab67f9f8a8923193763a5543cfe4defa
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SORBS3 IRAG1 DENND2B C2CD2

2.38e-04177764a8625d14682183cf77cb51eaf11bc15a3528f586
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SORBS3 IRAG1 DENND2B C2CD2

2.38e-041777643645e2f4a48283f290f85c49c3e79e3f58ac9aa6
ToppCellTCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9

ASXL1 HSPH1 RALGAPB ADNP

2.43e-04178764edc76b8f15056ec1c9a1c61a048b6331a92592d6
ToppCellPBMC-Mild-Hematopoietic-HSPC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MYCN IFTAP HEMGN PTK7

2.49e-041797642f690f933bf6b99abeb31766e0b22bdbe36c1ba0
ToppCellCOVID-19_Mild-Hematopoietic_SC-HSPC|COVID-19_Mild / Disease group, lineage and cell class

MYCN IFTAP HEMGN PTK7

2.49e-0417976419fcf48f5e02e4cb2b328efb4502f337e1282f72
ToppCellPBMC-Mild-Hematopoietic-HSPC-HSPC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MYCN IFTAP HEMGN PTK7

2.49e-041797644bb2debfc9e9f258cd38e797ef160bd440aad6af
ToppCellPBMC-Mild-Hematopoietic-HSPC-HSPC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MYCN IFTAP HEMGN PTK7

2.49e-041797643e2c937369b8190fd5d5a31689d029e6e89fb5e2
ToppCellCOVID-19_Mild-Hematopoietic_SC|COVID-19_Mild / Disease group, lineage and cell class

MYCN IFTAP HEMGN PTK7

2.49e-0417976450a073166e34bcfa52a62c4dafb3aef724e0fa8e
ToppCellFetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

FBXL22 IRAG1 CNTFR PTK7

2.59e-0418176425915e2500430a902db37d79a749ce2990b69810
ToppCellPBMC-Mild-Hematopoietic-HSPC-HSPC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

MYCN IFTAP HEMGN PTK7

2.59e-0418176454a19cf6a3b752e2391feb8b316bebee0e602d17
ToppCellPBMC-Mild-Hematopoietic-HSPC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

MYCN IFTAP HEMGN PTK7

2.59e-041817645b84625b1d3737708001b64f6da9360330d39a27
ToppCellPBMC-Mild-Hematopoietic-HSPC-HSPC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

MYCN IFTAP HEMGN PTK7

2.59e-04181764e7f7b519c2a01c15f26df11ec9b434c0d1630c7a
ToppCellCOVID-19_Severe-Hematopoietic_SC-HSPC|COVID-19_Severe / Disease group, lineage and cell class

MYCN IFTAP HEMGN PTK7

2.70e-041837644146b1c0e5f76d25226745abfa28f77127a444fc
ToppCellCOVID-19_Severe-Hematopoietic_SC|COVID-19_Severe / Disease group, lineage and cell class

MYCN IFTAP HEMGN PTK7

2.70e-0418376492aab7ce65aca17988bc2add4ff9fb8384e2c21b
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

SORBS3 IRAG1 DENND2B C2CD2

2.70e-04183764667717366cb181b8a04a347e64f0f5a4dfc6ee7f
ToppCelldroplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ARID4B BAZ2B PRRC2C ELK4

2.70e-0418376428cbf909424f3be4491d49832f0aca0386560814
ToppCellCalu_3-infected|Calu_3 / Cell line, Condition and Strain

ARID4B BAZ2B NR3C1 ZNF292

2.70e-041837648f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCelldroplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ARID4B BAZ2B PRRC2C ELK4

2.70e-041837643fa608aa6b119869ec3280dc388dfee57160e63a
ToppCellPCW_07-8.5-Neuronal-Neuronal_postreplicative-neuro_neuronal_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

CHL1 MAP6 CHD5 UNC13A

2.76e-04184764571136c832cb8c08457744152231537aa8e8abd7
ToppCellPBMC-Severe-Hematopoietic-HSPC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MYCN IFTAP HEMGN PTK7

2.76e-04184764a6169613c6493b947a176493f542368bfa935dab
ToppCellPBMC-Severe-Hematopoietic-HSPC-HSPC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

MYCN IFTAP HEMGN PTK7

2.76e-0418476451d0447699e3b8f01abbde83f26b748bc9f3c723
ToppCellPBMC-Severe-Hematopoietic-HSPC-HSPC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MYCN IFTAP HEMGN PTK7

2.76e-04184764cc01c19180861f491a8dc16d60fabd1215fc4525
ToppCellPBMC-Severe-Hematopoietic-HSPC-HSPC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

MYCN IFTAP HEMGN PTK7

2.76e-04184764f7b0bb45a9055ab34e98b251217f6ec38c75ca22
ToppCellPBMC-Severe-Hematopoietic-HSPC-HSPC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MYCN IFTAP HEMGN PTK7

2.76e-04184764492c680f0769ba4e651d09c2e8e5d5d271ed08aa
ToppCellPBMC-Severe-Hematopoietic-HSPC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

MYCN IFTAP HEMGN PTK7

2.76e-0418476426edbf84216538b80f1ffcc079ee6e385a71fbf9
ToppCellmetastatic_Brain-T/NK_cells-Naive_CD4+_T|T/NK_cells / Location, Cell class and cell subclass

TRABD2A EEF1D IGSF22 TMOD2

2.82e-041857642eee26c28b130be6163f27bc608384c054238501
ToppCelldroplet-Kidney-KIDNEY-1m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CHL1 COL6A3 MAP6 TMOD2

2.82e-04185764ca69499ba8c39b7ed6717d05685d6f70066a77bd
ToppCellLPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL6A3 HECTD2 ITSN1 IRAG1

2.82e-04185764e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3
ToppCellAdult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor

MAP6 SAXO2 DSCAML1 MORN3

2.82e-0418576430f4980dee6cd5959655f8d74049f3bfb5312611
ToppCell18-Distal-Epithelial-Epithelial|Distal / Age, Tissue, Lineage and Cell class

CHL1 CHD5 GRM7 UNC13A

2.82e-04185764d2a266724f3f70f746a78034f308d98f8b7a66e3
ToppCellTCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9

ARID4B OXR1 IRAG1 CHAMP1

2.88e-0418676403db813598b67b1e08f759758a1c2023396921fa
ToppCelldroplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SRRM1 ARID4B PRRC2C RALBP1

2.94e-04187764663991a8afe652e92363b64bcbd68c14d0307f0e
ToppCellFetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

FBXL22 IRAG1 DENND2B PTK7

3.00e-041887644d1e5f85342ae550086609d7680e32730b78b5d2
ToppCelldroplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SRRM1 ARID4B PRRC2C RALBP1

3.00e-04188764d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd
ToppCellLPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL6A3 FBXL22 HECTD2 IRAG1

3.00e-04188764293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11
ToppCellCOVID_vent-Myeloid-Monocytic-SC_&_Eosinophil|COVID_vent / Disease condition, Lineage, Cell class and subclass

MYCN HEMGN PDZD8 PTK7

3.06e-041897642157a2d40613f7d5ce2e7dbd266df441e449cdaf
ToppCellfacs-SCAT-Fat-24m-Mesenchymal-mesenchymal_progenitor|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADH7 BAG3 TMOD2 CNTFR

3.12e-04190764dc7e92f1b18d0f5efec11d09d56ba954d4f8b3bd
ToppCellfacs-SCAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADH7 BAG3 TMOD2 CNTFR

3.12e-041907640bb06df3d5a50416854370f234718c6cec3d773b
ToppCellfacs-SCAT-Fat-24m-Mesenchymal|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADH7 BAG3 TMOD2 CNTFR

3.12e-04190764008290bb5c79446681dd6bf354336c57ad0d6f13
ToppCellCOVID-19-lung-Artery_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type

CHL1 TRABD2A HSPH1 BAG3

3.12e-0419076407b675befcd1d0a9c90cb17b5d22323468325d51
ToppCelldroplet-Kidney-nan-21m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FBXL22 RTL3 IRAG1 GRM7

3.12e-04190764e04f47705851563515b6a66a2634cf7a574f7bda
ToppCell18-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class

COL6A3 FBXL22 CNTFR PTK7

3.18e-0419176486ce98d2c90c196474b06869de888cf5d1eed196
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)

ARID4B PRRC2C HSPH1 ZNF292

3.18e-041917641ecd9849d14d5ebf3daf610e83fb50820cafd3ed
ToppCell11.5-Distal|11.5 / Age, Tissue, Lineage and Cell class

COL6A3 EEF1D CNTFR PTK7

3.24e-04192764169b9ee2377beb9e4ad35bc82bb7a3dafe8f05b6
ToppCellhuman_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells)

ASXL1 ARID4B HSPH1 ZNF292

3.24e-04192764916fbec1c7ab7969bda711886ac88e877e30c280
ToppCellwk_15-18-Epithelial-PNS-FGFBP2+_Neural_progenitor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

MYCN PPRC1 TMOD2 NBEA

3.24e-04192764ab54d4bfc61ef7e3d765afe6e4a6d7011a301ecd
DrugCamptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A

ASXL1 TBC1D31 ARID4B MTF2 NR3C1 ADNP ZNF292

2.17e-061807574541_DN
Diseaseallograft inflammatory factor 1 measurement

HEMGN PRRC2A

1.96e-053762EFO_0020135
DiseaseBilateral Wilms Tumor

MYCN COL6A3 ASXL1

5.72e-0529763C2930471
DiseaseNephroblastoma

MYCN COL6A3 ASXL1

1.10e-0436763C0027708
Diseaseguanosine diphosphate measurement

BAZ2B NBEA

3.55e-0411762EFO_0010494
Diseasebenign prostatic hyperplasia

NUP107 UNC13A

5.84e-0414762EFO_0000284
Diseasesyndromic intellectual disability (implicated_via_orthology)

PDZD8 OPHN1

7.67e-0416762DOID:0050888 (implicated_via_orthology)
Diseaseepilepsy (implicated_via_orthology)

CHL1 SCN10A SLC1A7 UNC13A

8.45e-04163764DOID:1826 (implicated_via_orthology)
Diseaseautosomal dominant intellectual developmental disorder (is_implicated_in)

TLK2 ZNF292

8.68e-0417762DOID:0060307 (is_implicated_in)
DiseaseFetal Alcohol Syndrome

CHL1 ADNP

8.68e-0417762C0015923
DiseaseIntellectual Disability

CHL1 TLK2 OXR1 NBEA CHAMP1 ZNF292

1.04e-03447766C3714756
DiseaseAttention deficit hyperactivity disorder

GRM7 ZNF292

1.74e-0324762C1263846
DiseaseNeurodevelopmental Disorders

ADNP PTK7 ZNF292

1.80e-0393763C1535926
Diseaseplasma clusterin measurement

MTF2 GRM7

1.89e-0325762EFO_0007656
Diseasecardiac troponin T measurement

TLK2 TRABD2A BAG3 CNTFR

2.49e-03219764EFO_0005043

Protein segments in the cluster

PeptideGeneStartEntry
VAPKPATPDKVPAAE

UNC13A

401

Q9UPW8
FDPNPKPVSRIVKPQ

BHLHB9

186

Q6PI77
KQPFSIEEIEVAPPK

ADH7

31

P40394
PKPQPKVQEKADIPV

ADNP

591

Q9H2P0
KPPPVNVDSKPIEEK

ARID4B

986

Q4LE39
QEKPPDTPIVDPTVK

CHD5

671

Q8TDI0
VEVAKPVDFPSPKPI

BAZ2B

1696

Q9UIF8
VPKPPSIEEFSIVKP

MASTL

26

Q96GX5
EPLPEKIPENVPVKA

CHMP6

176

Q96FZ7
DPAVNPVPKPKRTFE

DENND2B

381

P78524
RQVEPPAKKPATPAE

EEF1D

136

P29692
HTEKPQPTKEEPKVP

ASXL1

556

Q8IXJ9
PPVPPNVAFKAEKEP

MTF2

351

Q9Y483
PEVPQIDVPNLKPIF

RALBP1

176

Q15311
EDEPPKNQKPKITPV

NOLC1

176

Q14978
PQKPALIPQPTFTEK

NUP107

771

P57740
AATPQKPEPKPDIVA

OPHN1

751

O60890
VLAPPPEEVQKAKTP

NRBP2

396

Q9NSY0
PEEVQKAKTPTPEPF

NRBP2

401

Q9NSY0
QEKPPPAQAKITIEP

MAP10

311

Q9P2G4
EPFKEPPKVEKPSVQ

MAP6

366

Q96JE9
EEIEFIVPSVPKFPK

CHL1

121

O00533
PEPILPIQPKTVKDF

HECTD2

121

Q5U5R9
CEPVVTQPKPKIESP

HSPH1

796

Q92598
PRPPPVEKSKEIAIE

IRAG1

266

Q9Y6F6
FLVVPPPQKDFAVEP

NHSL1

1206

Q5SYE7
EPDVLVEKPEKVVPP

PDZD8

611

Q8NEN9
DQKPIFNVIPPIPVG

NR3C1

346

P04150
EPVKFVPQDVPPEPK

PHF14

806

O94880
KVFPSVASPQKVVPE

HEMGN

116

Q9BXL5
QASKPPAPKTPIIEE

OXR1

36

Q8N573
VPEFVEKPQPVTAPE

IGSF22

66

Q8N9C0
PFVAQPPTCEVKPKP

IFTAP

141

Q86VG3
PPPVPAAKIEKDRTV

C2CD2

396

Q9Y426
VVKSPKVAPEEAPPR

SLC1A7

166

O00341
FVTTPSKKPPVEPVA

ELK4

191

P28324
VAVKVPPLIQPFEFP

DSCAML1

591

Q8TD84
EPQKPAPVSPESVKA

CHAMP1

206

Q96JM3
IEPQKPVFPETRKPG

CHAMP1

486

Q96JM3
AEKIPENEVPAPVKP

ITSN1

801

Q15811
KPVATKPEVPRPQAA

COL6A3

2961

P12111
IVKPDPPENVVARPV

CNTFR

201

P26992
LPVDITKVPPAPVNK

CC2D1A

541

Q6P1N0
PPVFVKPEKVVGVIG

GRM7

141

Q14831
VSQKPPPPSEKVEVK

BAG3

351

O95817
REVVEPVVPKEPQNP

PPRC1

431

Q5VV67
GAPQTEPTKVEVKPV

PPRC1

1046

Q5VV67
PVPVDQTKKEAEPIP

MED6

201

O75586
APEPTQFPIPEVKIL

MORN3

206

Q6PF18
AQKTPEFKEPQKPPE

RTL3

76

Q8N8U3
ELIPFVKPAPIEQEP

SARS1

466

P49591
EINKPPPPLVKVIED

TBC1D31

341

Q96DN5
SFDRSVVVPVKKPPP

NBEA

1786

Q8NFP9
PVDPVQPAKPTAYVK

PRR20G

36

P0DPQ3
TEPQRPVKEEEPKIP

MPIG6B

186

O95866
PPPGAPVVISVKQEE

FBXL22

196

Q6P050
QEKVEEKPPPAPSIA

PRRC2C

2861

Q9Y520
DEVAKIQTPPPKKEP

PRRC2A

871

P48634
VIQETIVPKEPPPEF

SF3A1

136

Q15459
EVQFPPKPVVTPEAK

TLK2

701

Q86UE8
QPFPKKAVDVFFPPE

CLTC

241

Q00610
VVFPFPVNKREPAPV

MYCN

191

P04198
CPFPQPKAEPELVVK

SCN10A

936

Q9Y5Y9
PELPEPSVKVKEPSV

SRRM1

221

Q8IYB3
EAPELPVKVNPTKPR

SELENOH

61

Q8IZQ5
PPRKLKFPEPQEVVE

SELENOH

101

Q8IZQ5
TVEVKQEEDIKPPPP

FSBP

151

O95073
EPEVIPVQKPVPVNE

ZNF292

666

O60281
IFAPKVPTLEVPAPE

TRABD2A

376

Q86V40
EIPKPIKPPTYQVLE

SORBS3

441

O60504
VPEPRPVPKNDVGFK

RALGAPB

1006

Q86X10
SFQPWEIPPPEVKKV

SAXO2

221

Q658L1
VVPAKRVPAPKAPDE

ZNF839

71

A8K0R7
EPDSPPEVRKPFITV

ZGRF1

861

Q86YA3
EPPVPVKETRPYQAV

TASOR2

1406

Q5VWN6
AEDKIFPVPEEPPVK

ZBED1

516

O96006
VQVLEKLKFTPPPQP

PTK7

496

Q13308
EPVPAQFQKVKPPKT

ZNF512

546

Q96ME7
KVKPVFEEPPNPTNV

TMOD2

171

Q9NZR1
VKPPAVAPEKDESPV

ZNF114

106

Q8NC26
SIKVKVVDFPDPPVA

MYBPC1

611

Q00872